Home india India Equity: Concord_Drugs (#538965) declares Quarterly Results. EPS = Rs 0.79 for quarter ended Jun 2021

India Equity: Concord_Drugs (#538965) declares Quarterly Results. EPS = Rs 0.79 for quarter ended Jun 2021

0
India Equity: Concord_Drugs (#538965) declares Quarterly Results. EPS = Rs 0.79 for quarter ended Jun 2021

Join the India Equity Telegram Group for analysis, updates and results

538965 has declared results for the period ended Jun 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

  • Sales for period ended Jun 2021 is Rs 20.22 cr compared to Rs 18.2 cr for period ended Jun 2020, a rise of 11.1%
  • Operating Profits reported at Rs 2.27 cr for period ended Jun 2021 vis-vis 0.96 for period ended Jun 2020 .
  • Operating Margins expanded 595.2 bps for period ended Jun 2021 vis-vis Jun 2020 .
  • The EPS for Jun 2021 was Rs 0.79 compared to Rs 0.39 for previous quarter ended Mar 2021 and Rs 0.19 for Jun 2020
  • The stock is trading at Rs 28.10 and a market cap of Rs 25 cr

[/s2If]

Trading Chart


Further analysis and Full Company Research with investing scores is available here: 538965

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter